Viktig informasjon i saken hentes i sanntid direkte fra EPO sitt register (European Patent Register), slik at du enkelt og raskt får oversikt i saken.
Beskrivelse Verdi
Saken / databasen er sist oppdatert info  
Tittel Tracers
Status
Hovedstatus
Detaljstatus
I kraft info Meddelt Patent meddelt (B1) (sjekk også detaljer i saken)
Patentnummer 343467
Søknadsnummer 20150888
Levert
Prioritet Ingen
Sakstype Nasjonal
Løpedag
Utløpsdato
Allment tilgjengelig
Meddelt
Søker Institutt for Energiteknikk (NO)
Innehaver Institutt for Energiteknikk (NO)
Oppfinner Helge Stray (NO) .... se mer/flere nedenfor
Fullmektig DEHNS NORDIC AS (NO)
Patentfamilie Se i Espacenet

The invention provides the use of at least one sparingly soluble ionic metal compound, each comprising a metal ion and at least one anion, in monitoring and/or validating the use of at least one chemical treatment agent in a subterranean reservoir. Typical compounds include oxides, sulphides, phosphates and molybdates of rare earth elements or yttrium. The inventions also provides a corresponding method for monitoring and/or validating the use of at least one chemical treatment agent in a subterranean reservoir. Tracer sources comprising at least one sparingly soluble ionic metal compound bound with a binder such as a polymer are also provided.

Se forsidefigur og sammendrag i Espacenet


B1

Beskrivelse

Tracers

Field of the invention

The present invention relates to methods for validating the effective use of scale inhibitors and tracer chemicals for use in such validation methods.

Background of the invention

The prevention of scale accumulation in petroleum wells is of great importance and scale inhibition treatments and control measures are performed regularly to maintain flow assurance. To carry out scale inhibition methods, scale inhibitor chemicals may be pumped into the reservoir, typically through the production well, and production is halted for a period so that the inhibitor can be deposited in the rock formation (e.g. by absorption or precipitation). When production is resumed, the chemicals will slowly be released from the rock and inhibit precipitation of scale in the surrounding formation and in the production tube. Scale inhibitor chemicals are designed to prevent precipitation of the most abundant types of scale found in petroleum wells (such as BaSO4, CaSO4, and CaCO3). Sub-stoichiometric scale inhibitors can impact the formation of initial clusters from sparingly soluble salts and thereby retard the formation of crystals and delay precipitations. It is, however, difficult to verify, using existing technology, whether the scale inhibitor chemicals have been distributed along the whole production tube, or if the chemicals have reached only some zones of the well. Furthermore, in certain configurations (e.g in horizontal wells) the pressure in some parts of the well (e.g. the “heel” part close to the well head) will be lower than in other parts (e.g. the “toe” part furthest away from the well head ). This potentially results in the scale inhibitor reaching only the low pressure parts such as the heel zone of the well. During current scale inhibition treatments, no monitoring of which parts of the well the scale inhibitor chemicals have reached is performed. As a result, certain areas may be treated inadequately and may accumulate scale at the expense of well performance. Alternatively, excessive scale treatments may be conducted in order to ensure that all areas are sufficiently treated. This is wasteful of both production time and materials. No methods have previously been proposed to monitor or validate the effectiveness of scale inhibitor treatment methods, particularly with regard to the areas treated. It would evidently be of considerable value to provide a method for monitoring such treatment.

The present inventors have now established that by use of appropriate tracers and conditions, a tracer system may be devised that can be used to monitor and/or validate the use of well treatment chemicals, such as scale inhibitors, in a petroleum well.

Summary of the Invention

In a first aspect, the present invention thus provides the use of a metal compound, sparingly soluble under normal production conditions, in monitoring for the presence of at least one chemical treatment agent along the well or in a subterranean reservoir. Such metal compounds, each comprising a metal ion, will typically be compounds which have a low solubility under the prevailing conditions of the reservoir but have an increased solubility under the conditions of the at least one chemical treatment agent. Solubility of the sparingly soluble metal compound in water at 50°C and pH 7 will preferably not be greater than 5 x 10-2 g/100 g.

In a further aspect, the invention also provides a method for monitoring for the presence of at least one chemical treatment agent in a subterranean reservoir, with said method comprising introducing at least one metal compound sparingly soluble under normal production conditions, each compound comprising a metal ion, to at least one site along the well or within said reservoir. At least one chemical treatment agent is then applied to the reservoir and at least one fluid stream produced from said reservoir is monitored for the presence and/or concentration of at least one metal compound. Typically, the metal ion in dissolved form of said at least one metal compound, is monitored. Solubility of the sparingly soluble metal compound in water at 50°C and pH 7 will preferably not be greater than 5 x 10-2 g/100 g.

In another aspect, the invention provides a tracer source placed at defined locations along the well and comprising a sparingly soluble metal compound wherein it is the dissolved form of the metal ion which is the tracer element. Solubility of the sparingly soluble metal compound in water at 50°C and pH 7 will preferably not be greater than 5 x 10-2 g/100 g.

Suitable sites within a reservoir may be along the well, for example, in sand screens at one or more production layers and/or within or close to production tubes at one or more known positions. Any position on the external or internal face of the tubing, or sites at the casing, or at any part of the subterranean equipment may be used for incorporating the metal compound. Other suitable sites include the insertion of the metal compounds within the rock formation of the reservoir at one or more known positions. All combinations of such sites may be used, as well as other sites which will be evident to the skilled worker.

Typical metal compounds appropriate for use in all aspects of the invention include salts, oxides and hydroxides of heavy metals such as rare earth metals and/or yttrium. Such compounds may particularly include molybdates, sulphides, phosphates, hydroxides and/or oxides.

Typical chemical treatment agents include scale inhibitors, many of which are well known in the art. In particular, scale inhibitors having a pH of around 7 to around 2 are highly suitable. Typically scale inhibitors may comprise at least one carboxylic acid moiety and/or at least one phosphonic acid moiety. Examples include Diethylenetriamine penta(methylphosphonic acid), Triethylenetetramine hexa(methylenephosphonic acid) and other N-phosphinomethylated poly alkylamines, phosphino polycarboxylic acids, polyacrylic acids, polymaleic acids, sulphonated polyacrylic acids and/or polyvinyl sulphonates.

Detailed Description of the Invention

Tracer technology is applied for different purposes and is frequently used for tracking fluid flowpaths and distribution in petroleum wells. One example is for monitoring in-flow of fluids to petroleum wells. Sources with different tracers can be placed along the production tube representing different production zones, and the tracer released after contact with a fluid can be identified in the produced fluids and give information on the in-flow pattern. One possibility is to insert the tracer sources under sand screens of the well. In this and other methods, the tracer can be incorporated into a polymer or another suitable matrix to allow for the controlled release over time upon exposure to the fluids. Such a system is described in patent US 6,645,769B2. Another possibility for placing the tracer sources at defined locations along the well is to use a retrofitting tool for installation in an already constructed well. The tool is used to position sleeves with a high inner diameter (so as to not significantly restrict flow) with open chambers containing tracer sources. Passing fluids are allowed to enter the chambers and release tracer compounds under certain conditions. The tracer sleeves can be fixed at defined positions along the well and be retrieved when necessary using a wireline, tractor or coiled tubing. This is a technique known to a person skilled in the art of reservoir technology, and a similar technique is described in patent US 8, 230,731B2. No known tracer method has previously been reported which can monitor or validate the use of well treatment chemicals such as scale inhibitors.

Preferred metals for use in the sparingly soluble ionic metal compound of the various aspects of the present invention are typically “rare metals”. Suitable metals for use in the various aspects described herein include metals with an atomic number of 31 or greater, preferably 39 or greater. Preferably the metals chosen for use in the various aspects of the invention will have a low content of metal ions naturally present in produced water (e.g. less than 20 ng l-1 in the relevant produced water). Such metals include particularly the rare earth elements (especially elements of atomic number 57 to 71) and certain other useful metals such as yttrium (atomic number, Z= 39), hafnium (Z=72), niobium (Z=41), gallium (Z=31) and indium (Z=49).

Rare earth elements and Yttrium (REE and Y) can form salts, oxides and other ionic compounds that have very low solubility in water under the conditions typically found in subterranean reservoirs such as petroleum reservoirs. For instance phosphate salts of REE (especially in oxidation state 3+) are soluble in water at the 10-10 to 10-11 g/100 g range, while the solubility for most of REE and Y oxides and hydroxides ranges from 10-3 to 10-5 g/100 g, depending on the element and temperature conditions.

For use in all aspects of the present invention, the ionic metal compound will preferably have a solubility in water at 90°C and pH between 5 and 9 (e.g. pH 7) of no greater than 5 x 10-2 g/100 g, preferably no greater than 10-3 or 10-5 g/100 g (e.g.10-3 to 10-20 g/100 g).

For use in any aspect of the present invention, the sparingly soluble ionic metal compounds may have any appropriate anion providing suitable low solubility in water (see above) and higher solubility in the presence of well treatment chemicals such as scale inhibitors. Suitable anions include oxide, hydroxide, sulphide, molybdate and phosphate ions.

The concentration of REE and Y in produced water from petroleum wells under normal production conditions will depend on the composition of the surrounding rock formation, but will usually be low and similar to that found in seawater (0.1-17 ng l-1) [1,2]. However, when in contact with scale inhibitor chemicals, REE and Y salts (or oxides/hydroxides) may be dissolved to a greater extent. Without being bound by theory, it is believed that the complexing effects of the scale inhibitors serve to increase the solubility of the metal ions from the sparingly soluble salts and thus bring the salts into solution. Sparingly soluble oxides, hydroxides or salts of other rare elements, such as hafnium, niobium, gallium and indium, behave similarly. It follows that when suitable metal (e.g. REE and Y) salts, hydroxides or oxides are placed at designated locations along the production well, the concentration of the corresponding metal ions (e.g. of REE and/or Y) found in the produced water under normal production conditions will be very low, but will increase significantly in contact with treatment (e.g. scale inhibitor) chemicals. Once production has resumed following a treatment (e.g. scale inhibition), this increase in the concentration of metal ions (e.g. ions of REE and/or Y) in the produced water can be used to verify that the scale inhibition chemicals have indeed reached the intended zones along the well.

The metal ions of the ionic metal compound(s) should be detectable to a low concentration in order to provide good sensitivity without requiring large quantities to be placed in the reservoir. Typically the metal ions will be detectable down to a level of 10 ng/l in produced water, preferably down to 1 ng/l and more preferably 0.1 ng/l (or better). Detection may be by any method known in the art including, for example, mass spectrometry (e.g. inductively coupled plasma high resolution mass spectrometry).

When the dissolved metal ions (e.g. of REE and Y) have been washed out by the produced fluids, the level of the tracers (metal ions) found in the produced fluids will return to a similar level as before the (scale inhibition) treatment and further monitoring of chemical treatment will not be possible without further placement of tracers. However, the tracer particles (containing, for example the sparingly soluble ionic metal compounds) can be placed in the well in such a way that only a portion of the tracer is released each time the reservoir is treated with a well-treatment chemical (e.g. scale inhibitor), as explained in greater detail herein. In this way, the effectiveness of multiple treatments may be validated. When, for instance, a sparingly soluble ionic metal compound (e.g. REE oxide) is mixed into a polymer and exposed to a scale inhibitor, the ionic metal compound (e.g. REE oxide) in the surface layer will be dissolved, and pores in the polymer surface layer will be created. The next time that the tracer source is exposed to the scale inhibitor, the treatment chemicals will enter the pores and dissolve tracer particles (ionic metal compounds) deeper in from the polymer surface. The installed tracer sources can, therefore, be used several times to verify contact with chemicals such as scale inhibitors when treatment (scale inhibition) operations are repeated. The examples below demonstrate that the tracer source may be configured such that only a small fraction of the ionic metal compound is dissolved with each treatment. It is thus preferred that less than 50%, preferably less than 10% and more preferably less than 1%, of the ionic metal compound is dissolved when a single well treatment with a well treatment chemical (as described herein) is employed.

In the patent US 8,230,731B2, a technique for the detection of water incursion in a petroleum production well using several tracer compounds, including lanthanides, is described. The use of lanthanides and other rare elements for the monitoring of the in-flow of fluids in petroleum production wells is described in the patent WO 2007/102023A1. A third patent where lanthanide compounds are used as tracers is US 4,755,469A, where the tagging oil with lanthanide metal salts of fatty acids is described for various purposes such as oil flow monitoring and the identification of an oil spill. None of these documents relate to the use of well treatment chemicals or the monitoring of well treatments (e.g. scale inhibition) by the use of tracers. The present invention differs from the above mentioned patents in that it provides a method for the verification that scale inhibitor chemicals have reached the intended zones in a petroleum production well.

In the present invention, the ionic metal compounds are typically placed at sites of interest in the subterranean reservoir (e.g. petroleum reservoir). Where more than one ionic metal compound is used, these will generally comprise different metal ions and will be placed at separate positions in the reservoir, preferably at different production layers. At least one ionic metal compound will be employed in the uses and methods of the invention and this may be at least two (e.g.2 to 10 or 2 to 20) different metal compounds, each comprising ions of a different metal or different isotope.

Typically, the ionic compounds used in the various aspects of the present invention will comprise a metal ion having natural isotopic abundance. However, in one embodiment of the invention suitable for application to all aspects described herein, the ionic compound may comprise at least one metal isotope at greater than its natural abundance. Such isotopes will typically be non-radioactive (stable) isotopes. Different isotopes may be distinguished by detection methods such as the massspectroscopic methods described herein. Thus, where “different metals” or “different metal ions” are referred to herein, these may be chemically different elements or may be different isotopes of the same chemical element (or a combination of different elements and different isotopes) where context allows. Isotopic labeling allows for a much greater diversity of labels but will potentially be more expensive than labeling with different metal elements and so will preferably be used where a sufficient number of different suitable metal elements are not available.

Obviously, where the detection sensitivity is sufficient, mixtures of isotopes may be used, provided that the ions originating from different sites can be distinguished. For example, if a metal has a common isotope of atomic mass Z and rare isotopes Z+1 and Z+2, salts having mostly Z with a low percentage Z+1 can be distinguished from salts having mostly Z and a low percentage Z+2, providing sufficient detection sensitivity is possible. It may be more economical to apply a larger quantity of a material with a slight isotopic enhancement than to apply a small amount of material of high isotopic purity. Thus, isotopic labeling may be carried out by enhancing at least one isotope by at least 1% above its natural abundance, preferably at least 5% and more preferably at least 10% (e.g.10 to 99%) above its natural abundance.

Tracer sources (such as polymer rods) containing sparingly soluble metal (e.g. REE and/or Y) salts (e.g. oxides) can be placed at known positions in a reservoir using well known methods. For example, the tracers may be placed under sand screens during the construction of a new well or be placed in chambers in sleeves inserted into an existing production well using a tool that is operated from the well head. Several such sources (e.g. treated sand screens or sleeves), each containing different tracer(s) can be located in different zones along the production well. The ionic metal compounds (e.g. REE or Y salts or oxides) are sparingly soluble under normal production conditions giving rise to low background concentrations of metal ions (e.g. REE and/or Y ions) in the produced waters. When in contact with scale inhibition chemicals, the dissolution of the metal (e.g. REE and/or Y) salts will increase significantly, resulting in an increased concentration of metal ions in the produced water when production is resumed. Where the presence of a metal ion at above background level is detected, this indicates that the well treatment chemical (e.g. scale inhibitor) reached the site of the tracer which comprises that metal. Thus, the actual distribution of the scale inhibition chemicals along the well can be verified by analysis of the produced water and comparison of measured metal ions with known sites of ionic metal compound tracers.

The sparingly soluble tracers can be mixed into a polymer, but can also be present in other forms. Where the sparingly soluble ionic compound is mixed with an inert material such as a polymer, ceramic or glass, the inert material will typically be little changed by exposure to the reservoir environment and the ionic compound will dissolve little in formation water. However, when the reservoir is treated with at least one chemical treatment agent such as a scale inhibitor, the ionic material will be partially dissolved and produced from the well. This will create pores in the inert material allowing subsequent treatment chemicals to access deeper into the material and dissolve more of the sparingly soluble compound. The application of poly methyl methacrylate (PMMA) is described in the examples below, but many different types of polymers can be employed, for instance epoxy resins, melamine-formaldehyde resins, among others. The tracers may also be present as layers of sintered salts or oxides on the surface of ceramic materials or metals, or mixed into such materials. REE and Y salts are exemplified below, but sparingly soluble salts of other rare elements such as hafnium, niobium, gallium and indium are expected to function equally as well.

Tracer sources comprising at least one a sparingly soluble ionic metal compound mixed and solidified with at least one polymer or ceramic material comprise a further aspect of the present invention.

The tracer sources of the present invention comprise at least one least one a sparingly soluble ionic metal compound as described herein, bound with at least one polymer or ceramic material. Suitable materials will be well known to the skilled worker and include polymer, ceramic materials and glass materials such as those described herein. Preferred sparingly soluble ionic metal compounds for all aspects of the present invention, particularly the tracer sources include oxides, sulphides, phosphates and molybdates, particularly of rare earth elements (REEs) or yttrium (Y). Oxides of Eu, Pr and Gd are particularly appropriate, such as Eu2O3,Pr2O3 and/or Gd2O3. The tracer sources will be bound into rods, sheets, blocks, rings, spheres, spheroids, tubes, liners or any shape suitable for application to the reservoir. The binding material will typically be a material that is insoluble in the formation fluids such as PMMA, epoxy resins, melamine-formaldehyde resins or any suitable ceramic or glass material including silica, titania, alumina and mixtures thereof.

In the present invention the use of sparingly soluble ionic metal compounds (e.g. REE and/or Y salts or oxides) as tracers for the verification that scale inhibitor chemicals have reached intended zones in a reservoir is described. Tracer sources of at least one, preferably at least two (e.g.2 to 10) sparingly soluble ionic metal compounds (e.g. REE and/or Y salts or oxides) are located in different zones of a petroleum production well, and when treatment chemicals (e.g. scale inhibitor solutions) are pumped into the well, the verification of its contact with the different zones of the well can be achieved. The sparingly soluble ionic metal compounds are gradually dissolved by the scale inhibitor chemicals and the amounts of metal ions (e.g . ions of REE and/or Y elements) in the produced water samples collected from the well head are determined when production is resumed.

Many sparingly soluble ionic metal compounds, such as oxides, hydroxides and sulfides of rare elements will be more soluble at low pH than at pH 6-8 normally found in produced water. The present invention may therefore also be used to verify that chemicals used in acid treatment of a well have reached the intended zones. The ionic metal compound (e.g. rare element) tracers are for this application limited to acid soluble compounds (e.g. those having a solubility in water at pH 2 of greater than 510-2g / 100g, preferably at least 0.1 g/100g, such as 0.2 to 20 g/100g) such as oxides, hydroxides or sulfides.

Other oil field chemicals used may include corrosion inhibitors, chemicals to inhibit deposition of wax, asphaltenes or naphthenates. The verification that oil field chemicals other than scale inhibitors and/or acids have reached the intended zones may be achieved by co-introduction into the reservoir with a scale inhibitor, chelator or acid treatment compound that dissolves the tracers – the chemical and scale inhibitor, acid treatment compound and/or chelator are injected at the same time - , or injection of scale inhibitor, acid treatment compound and/or chelator could follow injection of the main oil field chemical. As used herein, the term “chemical treatment agent” therefore includes single agents, such as scale inhibitors and/or acid treatment chemicals. These will typically serve in themselves to solubilize the sparingly soluble ionic compounds referred to herein. Additionally or alternatively, the chemical treatment agents may comprise at least a portion of at least one scale inhibitor, acid and/or chelating compound. This second chemical agent serves to “tag” the first agent by solubilizing the ionic compounds and therefore allowing the presence of the mixture in the region of the ionic compound to be validated. Acids and chelating agents are well known in the art and include mineral acids and organic acids, mono- di- and/or multi-dentate chelators and similar compounds. The chemical treatment agent may comprise a primary treatment agent (such as corrosion inhibitors, chemicals to inhibit deposition of wax, asphaltenes and/or naphthenates) and a secondary chemical treatment agent (such as an acid, chelating agent and/or scale inhibitor). In this embodiment (applicable to all aspects of the invention), the secondary agent will typically be present at less than 50% (e.g.0.1% to 50% or 1 to 25%) of the concentration of the primary chemical treatment agent. The preferred ionic compounds and tracer sources will be those described herein in all aspects.

Brief description of drawings

Figure 1 is a graph showing a plot of the concentration of Pr and Er versus the accumulated elution volumes of collected fractions from leaching experiments with poly methyl methacrylate (PMMA) rods containing 30% (w/w) Pr2O3 and Er2O3 at 70oC. The rods were leached with artificial formation water (pH 7), scale inhibitor solution (pH 3.9) and formation water respectively.

Figure 2 is a graph showing a plot of the accumulated concentration of Eu, Pr and Gd versus time of sampling after the start of the first flow-rig leaching experiment with PMMA rods containing 12.5% (w/w) Eu2O3, 6.3% Pr2O3 and 6.3% Gd2O3 at 80oC. The rods were first leached with tap water and then with scale inhibitor solution (pH 6.9).

Figure 3 is a graph showing a plot of the accumulated concentration of Eu, Pr and Gd versus time of sampling after the start of the second flow-rig leaching experiment with PMMA rods containing 12.5% (w/w) Eu2O3, 6.3% Pr2O3 and 6.3% Gd2O3 at 80oC. The rods were first leached with tap water and then with scale inhibitor solution (pH 6.9).

Examples

Example 1

The REE oxides Pr2O3 and Er2O3 were mixed into PMMA at a concentration of 30% by weight and molded into each of two rods of size 3x8x75 mm. The rods were installed in a glass column and the void volume was filled up with 3mm glass beads. Artificial formation water equivalent to formation water from the Gullfaks field on the Norwegian continental shelf was pumped through the column at a flow rate of 0.5 ml/min. The temperature was kept at 70oC throughout the experiment. The eluted water was collected in fractions at volumes ranging from 30 to 760 ml, and the concentration of Pr and Er were analyzed using inductively coupled plasma high resolution mass spectrometry (HR-ICP-MS). After nearly 6 days (4300 ml) of formation water flow, the eluent was changed to a scale inhibitor solution with a pH of 3.9. This scale inhibitor solution was pumped through the column for a period of 5 hours. The Pr concentration leached by the flow of fluid increased from a mean concentration of 76 ng/ml (with formation water) to a peak value 6.2 mg/ml (with scale inhibitor solution). The corresponding values for the Er concentration were 83 ng/ml and 8.8 mg/ml respectively. The concentration of Pr and Er then returned to near pre-inhibitor concentrations when the column was once again eluted with the formation water. An increase in eluted Pr and Er concentration by a factor of approximately 100 was thus achieved when the REE oxides Pr2O3 and Er2O3 were in contact with the scale inhibitor. A plot of the results from the leaching experiment is shown in Figure 1. Of the total amount of 0.5g Eu2O3 present in the rod, only about 0.8mg (approx.

0.16%) was leached out during the experiment. Repeated treatment with scale inhibitors would thus be expected to yield further peaks in metal ion concentration.

Example 2

A flow rig was used in the following experiment, consisting of a 4 m long steel tube with inner diameter 72 mm connected to a casing within which a 2 m long tool was installed. The tool consists of chambers for installing up to 30 tracer rods and the chambers have openings to allow for fluid to enter and come in contact with the tracer rods. The inner diameter of the tool is 145 mm, and the volume of the flow rig is calculated to be approximately 50 liters. Tracer rods with a size of 9x28x500 mm were placed in the tool beforehand, each containing different REE oxides. The tracer rods were made by mixing 10 to 20 g of rare earth oxide powder (Eu2O3, Pr2O3 and Gd2O3 ) into a PMMA polymer before hardening. The flow rig was connected to a reservoir filled with 1000 liters of tap water which was circulated at a flow rate of 490 L/min and a constant temperature of 80oC. The total volume of fluid in the system was, therefore, 1050 liters during the tap water circulation period which extended to 3 hours and 20 minutes during the first leaching experiment. Samples of the circulating tap water were taken at approximately 1 hour intervals and analyzed for their concentration of REE (Eu, Pr and Gd) using HR-ICP-MS. The concentration of Eu in the circulating tap water was found to be 50 pg/ml at the start of the experiment and 100 pg/ml after 3 hours and 20 minutes. Once a volume corresponding to the total volume of the fluid in the flow rig had passed over the tracer rods 93 times (98 m3), a scale inhibitor solution with a pH of 6.9 was pumped from a 250 liter reservoir and circulated through the flow rig. Samples of the scale inhibitor solution were collected at intervals of approximately 10 minutes and analyzed for REE concentration. The results from the leaching experiment with rods containing Eu2O3, Pr2O3 and Gd2O3 are plotted in Figure 2. The higher concentration of Eu observed in the circulated scale inhibitor solution compared to Pr and Gd is due to the higher concentration of Eu2O3 in the tracer rods. The concentration of Pr2O3 and Gd2O3 was 6.5% (w/w), while the concentration of Eu2O3 was 12.5%. Already after 2 minutes of circulation with scale inhibitor or when a volume of twice the total volume in the rig had been exposed to the tracer rods, a significant increase in the concentration of REE was observed. After about 50 minutes, or 80 circulations of scale inhibitor solution, the concentration of Eu leached had increased to around 100 ng/ml, approximately 1000 times higher than that observed in the tap water. The flow rig was then flushed with tap water and a second leaching experiment was completed. The results from the second leaching experiment are shown in Figure 3. The total amount of Eu2O3 dissolved by the scale inhibitor solution during the two leaching experiments was calculated as 22.5 mg, corresponding to 0.11% of the total amount of Eu2O3 (20 g) molded into the tracer rod.

References Cited

PATENT DOCUMENTS

US 6,645,769 B2 11/2003 Tayebi et al.

US 4,755,469 7/1988 Showalter et al.

WO 2007/102023 A1 9/2007 Green et al.

US 8,230,731 B2 7/2012 Dyer et al.

OTHER PUBLICATIONS

[1] Qiang Fu, Limin Yang, Qiuquan Wang, Talanta 72 (2007) 1248-1254

[2] Yanbei Zhu, Akihide Itoh, Eiji Fujimori, Tomonari Umemura, Hiroki Haraguchi, Journal of Alloys and Compounds 408-412 (2006) 985-988

Krav

Claims:1) Use, in monitoring for the presence of at least one chemical treatment agent along the well or in a subterranean reservoir,of at least one metal compound sparingly soluble under normal production conditions, each comprising a metal ion,characterised in thatthe sparingly soluble metal compound has a solubility in water at 50 C and pH7 of no greater than 5 x 10 -2 g/100 g.2) Use as claimed in claim 1 wherein the sparingly soluble metal compound is a salt, oxide or hydroxide of a metal having atomic number of 31 or greater.3) Use as claimed in any preceding claim wherein the sparingly soluble metal compound is a salt, oxide or hydroxide of a metal selected from the rare earth elements, yttrium, hafnium, niobium, gallium and indium.4) Use as claimed in any preceding claim wherein the chemical treatment agent is a scale inhibitor.5) Use as claimed in any preceding claim wherein the chemical treatment agent is a scale inhibitor comprising at least one carboxylic acid moiety and/or at least one phosphonic acid moiety.6) Use as claimed in any preceding claim wherein said at least one metal ion is detectable in produced water down to a level of at least 10 ng/l.7) A method for monitoring for the presence of at least one chemical treatment agent in a subterranean reservoir, said method comprising;i) introducing at least one metal compound sparingly soluble under normal production conditions, each compound comprising a metal ion, to at least one site along the well or within said reservoir,ii) applying said at least one chemical treatment agent; andiii) monitoring at least one fluid stream produced from said reservoir for the presence and/or concentration of the dissolved form of at least one metal ion comprised in said at least one metal compound,characterised in that the sparingly soluble metal compound has a solubility in water at 50 C and pH7 of no greater than 5 x 10 -2 g/100 g.8) The method of claim 7 wherein said at least one metal ion is detectable in produced water down to a level of at least 10 ng/l.9) The method of claim 7 or claim 8 wherein said metal compound is dissolved to no more than 10% by a single treatment of the reservoir with a chemical treatment agent.10) The method of any of claims 7 to 9 wherein at least two sparingly soluble metal compounds comprising different metal ions are placed in two separate positions in said reservoir.11) The method of any of claims 7 to 10 wherein said sparingly soluble metal compound is placed in the form of a tracer source comprising said compound and at least one polymer.12) The method of any of claims 7 to 11 wherein said sparingly soluble metal compound is placed in a sand screen and/or in an annular ring within a production pipe.13) The method of any of claims 7 to 12 wherein the chemical treatment agent comprises at least one scale inhibitor, acid and/or chelator.14) The method of any of claims 7 to 13 wherein the chemical treatment agent comprises a primary treatment agent and a secondary treatment agent, wherein the secondary treatment agent is at least one selected from a scale inhibitor, an acid, a chelator and mixtures thereof.15) A tracer source placed at defined locations along the well comprising a sparingly soluble metal compound,wherein it is the dissolved form of the metal ion which is the tracer element, andcharacterised in thatthe sparingly soluble metal compound has a solubility in water at 50 C and pH7 of no greater than 5 x 10 -2 g/100 g.16) A tracer source of Claim 15, inserted under a sand screen or installed in an open chamber in the well.17) A tracer source of Claim 15 or 16, bound with a polymer, a ceramic or a glass matrix.18) A tracer source of Claim 15, 16 or 17 bound with polymer, where preferred polymers are PMMA, epoxy resins, or melamine-formaldehyde resins.19) A tracer source of Claim 15, 16, 17 or 18, where the tracer source bound to the polymer takes the form of rods, sheets, blocks, rings, spheres, spheroids, tubes, liners or any shape suitable for application to the reservoir. Patentkrav til publikasjon1) Anvendelse ved monitorering av tilstedeværelse av minst ett kjemisk behandlingsmiddel langs brønnen eller i et underjordisk reservoar av minst en metallforbindelse som er tungt løselig under normale produksjonsbetingelser og som hver omfatter ett metall-ionkarakterisert ved atden tungt løselige metallforbindelsen har en løselighet ved 50oC og pH7 ikke høyere enn 5x10-2 g/100g.2) Anvendelse ifølge krav 1 hvori den tungt løselige metallforbindelsen er et salt, oksid eller hydroksid av et metall med atomnummer 31 eller høyere.3) Anvendelse ifølge hvilket som helst av de foregående krav hvori den tungt løselige metallforbindelsen er et salt, oksid eller hydroksid av metall fra de sjeldne jordartselementene, yttrium, hafnium, niob, gallium og indium.4) Anvendelse ifølge hvilket som helst av de foregående krav hvori det kjemiske behandlingsmiddelet er en avleiringshemmer.5) Anvendelse ifølge hvilket som helst av de foregående krav hvori det kjemiske behandlingsmiddelet er en avleiringshemmer som har minst en karboksylgruppe og/eller minst en fosfonyl-gruppe.6) Anvendelse ifølge hvilket som helst av de foregående krav hvori nevnte minst ett metall-ion kan detekteres i produsert vann ned til et nivå på 10ng/l eller lavere.7) En fremgangsmåte for monitorering av tilstedeværelsen av minst ett kjemisk behandlingsmiddel i et underjordisk reservoar og hvor nevnte fremgangsmåten innbefatter:i) plassering av minst en metallforbindelse som er tungt løselig under normale produksjonsbetingelser, hvor hver forbindelse omfatter et metall-ion, i minst en lokasjon langs brønnen i nevnte reservoarii) tilføring av nevnte minst ett kjemisk behandlingsmiddel; ogiii) monitorering fra minst en fluid-strøm produsert fra nevnte reservoar tilstedeværelsen av og/eller konsentrasjonen av den oppløste formen av minst ett metall-ion inkludert i nevnte minst en metallforbindelsekarakterisert ved atden tungt løselige metallforbindelsen har en løselighet i vann ved 50oC og pH7 ikke større enn 5x10-2 g/100g.8) Fremgangsmåten ifølge krav 7 hvori nevnte minst ett metall-ion kan detekteres i produsert vann ned til et konsentrasjonsnivå på 10 ng/l eller lavere. 9) Fremgangsmåten ifølge krav 8 og 9 hvori mindre enn 10% av nevnte metallforbindelse blir oppløst ved hver enkelt behandling av reservoaret med et kjemisk behandlingsmiddel.10) Fremgangsmåten ifølge kravene 7 til 9 hvori minst to tungt løselige metallforbindelser omfattende forskjellige metall-ioner er plassert ved forskjellige lokasjoner i nevnte reservoar.11) Fremgangsmåten ifølge kravene 7 til 10 hvori nevnte tungt løselige metallforbindelse foreligger i form av en sporingsstoff-kilde omfattende nevnte forbindelse og minst en polymer.12) Fremgangsmåten ifølge kravene 7 til 11 hvori nevnte tungt løselige metallforbindelse er plassert i en sandskjerm og/eller i annulus i et produksjonsrør.13) Fremgangsmåten ifølge kravene 7 til 12 hvori det kjemiske behandlingsmiddelet omfatter minst en avleiringshemmer, av syre og/eller en kompleksbinder (chelator).14) Fremgangsmåten ifølge kravene 7 til 13 hvori den kjemiske behandlingen utgjøres av en første og annen behandling hvor den andre behandlingen utgjøres av minst en valgt fra en avleiringshemmer, en syre, en kompleksbinder og en blanding av disse.15) En sporingsstoff-kilde plassert ved definerte lokasjoner langs brønnen som omfatter en tungt løselig metallforbindelse hvor det er den oppløste formen av metall-ionet som utgjør sporingsstoffet, og karakterisert ved atden tungt løselige metallforbindelsen har en løselighet i vann som ved 50oC og pH 7 ikke er større enn 5x10-2 g/100g.16) En sporingsstoff-kilde ifølge krav 15 plassert under en sandskjerm eller installert i et åpent kammer i brønnen.17) En sporingsstoff-kilde ifølge kravene 15 eller 16 som er bundet til en polymer, et keramisk materiale eller i glass.18) En sporingsstoff-kilde ifølge kravene 15, 16 eller 17 bundet med en polymer hvor den foretrukne polymeren er PMMA, epoksy resiner eller melamin-formaldehyd resiner.19) En sporingsstoff-kilde ifølge kravene 15, 16, 17 eller 18 hvori sporingsstoff-kilden bundet til polymeren har form av staver, ark, blokker, ringer, kuler, rør, liners eller hvilken som helst annen form passende for reservoaret.
Hva betyr A1, B, B1, C osv? info
Institutt for Energiteknikk
Postboks 40 2027 KJELLER NO ( LILLESTRØM kommune, Akershus fylke )

Org.nummer: 959432538
  • Foretaksnavn:
  • Foretaksform:
  • Næring:
  • Forretningsadresse:
     

Kilde: Brønnøysundregistrene
Institutt for Energiteknikk
Postboks 40 2027 KJELLER NO ( LILLESTRØM kommune, Akershus fylke )

Org.nummer: 959432538
  • Foretaksnavn:
  • Foretaksform:
  • Næring:
  • Forretningsadresse:
     

Kilde: Brønnøysundregistrene
Gåsebyveien 1 1481 HAGAN NO ( NITTEDAL kommune, Akershus fylke )
Sigurd Hoels vei 100, H0102 0655 OSLO NO ( OSLO kommune, Oslo fylke )
Fullmektig i Norge:
DEHNS NORDIC AS
Gaustadalléen 21 0349 OSLO NO ( OSLO kommune, Oslo fylke )

Org.nummer: 925704261
Din referanse: -
  • Foretaksnavn:
  • Foretaksform:
  • Næring:
  • Forretningsadresse:
     

Kilde: Brønnøysundregistrene
2 hendelser
  1. hendelse  
Patentstyrets saksnr. 2023/03294
Din referanse: IFE   Levert  
Gjeldende status Avgjort

Avsender

DEHNS NORDIC AS
Gaustadalléen 21 0349 OSLO NO ( OSLO kommune, Oslo fylke )

Org.nummer: 925704261

Statushistorie for 2023/03294

Liste over statusendringer i sakshistorikk
Hovedstatus Beslutningsdato, detaljstatus
Avgjort Forespørsel tatt til følge
Under behandling Mottatt

Korrespondanse for 2023/03294

Liste over sakshistorikk og korrespondanse
Dato Type korrespondanse Journal beskrivelse
Utgående GH Forespørsel
02-01 Via Altinn-sending GH Forespørsel
Innkommende, AR540003571 Generell henvendelse
01-01 Generell henvendelse Generell henvendelse
01-02 Annet dokument 2022-12-29 Dehns AS transfer to Dehns Nordic AS (1)
01-03 Fullmakt Leogriff generalfullmakt IFE 2009
  2. hendelse  
Patentstyrets saksnr. 2015/09389
Din referanse: IFEP0108 RA   Levert  
Gjeldende status Avgjort

Avsender

IPR SA
c/o Leogriff Kristian Augusts gate 7B 0164 OSLO NO ( OSLO kommune, Oslo fylke )

Org.nummer: 993594105

Statushistorie for 2015/09389

Liste over statusendringer i sakshistorikk
Hovedstatus Beslutningsdato, detaljstatus
Avgjort Forespørsel tatt til følge
Under behandling Mottatt

Korrespondanse for 2015/09389

Liste over sakshistorikk og korrespondanse
Dato Type korrespondanse Journal beskrivelse
Utgående GH Forespørsel
02-01 Via Altinn-sending GH Forespørsel
Innkommende Generell henvendelse
01-01 Generell henvendelse Generell henvendelse
01-02 Fullmakt Leogriff DELEGATION OF IP.COOP
01-03 Fullmakt Generalfullmakt IFE til leogriff
01-04 Fullmakt Generalfullmakt Leogriff til IPR SA

WO 2015/092310 A1 (A1)

WO 2007/102023 A1 (A1)

WO 2005/054132 A1 (A1)

WO 200/7056661 A2 (A2)

EP 1355038 A1 (A1)

WO 2013/180574 A1 (A1)

Statushistorie

Liste over statusendringer i sakshistorikk
Hovedstatus Beslutningsdato, detaljstatus
Meddelt Patent meddelt (B1)
Under behandling Godkjent til meddelelse
Under behandling Andre og senere realitetsskriv foreligger
Under behandling Andre og senere realitetsskriv foreligger
Under behandling Andre og senere realitetsskriv foreligger
Under behandling Andre og senere realitetsskriv foreligger
Under behandling Første realitetsuttalelse foreligger
Under behandling Formaliakontroll utført
Under behandling Mottatt

Korrespondanse

Liste over sakshistorikk og korrespondanse
Dato Type korrespondanse Journal beskrivelse
Utgående PT Registreringsbrev Nasjonal Patent (15) (PT20150888)
23-01 Brev UT PT Registreringsbrev Nasjonal Patent (15) (PT20150888)
Utgående Intention to grant
22-01 Brev UT Intention to grant
Innkommende, AR288423548 Korrespondanse (Hovedbrev inn)
21-01 Korrespondanse (Hovedbrev inn) Korrespondanse (Hovedbrev inn)
21-02 Beskrivelse Beskrivelse
21-03 Krav Krav
Utgående Realitet patent
20-01 Brev UT Realitet patent
Innkommende, AR275953557 Korrespondanse (Hovedbrev inn)
19-01 Korrespondanse (Hovedbrev inn) Korrespondanse (Hovedbrev inn)
19-02 Krav Krav
Innkommende, AR275216727 Korrespondanse (Hovedbrev inn)
18-01 Korrespondanse (Hovedbrev inn) Korrespondanse (Hovedbrev inn)
18-02 Beskrivelse Beskrivelse merket
18-03 Krav Krav NO ren
18-04 Beskrivelse Beskrivelse ren
18-05 Krav Krav ENG merket
18-06 Hovedbrev Hovedbrev
Utgående Realitet patent
17-01 Brev UT Realitet patent
Innkommende, AR252472596 Korrespondanse (Hovedbrev inn)
16-01 Korrespondanse (Hovedbrev inn) Korrespondanse (Hovedbrev inn)
16-02 Krav Krav merket
16-03 Hovedbrev Hovedbrev
16-04 Krav Krav ren
Utgående Realitet patent
15-01 Brev UT Realitet patent
Utgående PT Batch Varsel om betaling av første årsavgift (3317)
14-01 Brev UT PT Batch Varsel om betaling av første årsavgift (3317)
Innkommende, AR175915832 Korrespondanse (Hovedbrev inn)
13-01 Korrespondanse (Hovedbrev inn) Korrespondanse (Hovedbrev inn)
13-02 Krav Krav ren
13-03 Hovedbrev Hovedbrev
13-04 Krav Krav merket
Innkommende, AR167354934 Korrespondanse (Hovedbrev inn)
12-01 Korrespondanse (Hovedbrev inn) Korrespondanse (Hovedbrev inn)
Utgående Bekreftelse på patentsøknad
10-01 Brev UT Bekreftelse på patentsøknad
Innkommende Korrespondanse (Hovedbrev inn)
11-01 Korrespondanse (Hovedbrev inn) Korrespondanse (Hovedbrev inn)
Utgående Realitet patent
09-01 Brev UT Realitet patent
09-02 Vedlegg PT report 05:42:48
09-03 Vedlegg PT report 06:31:25
Innkommende, AR149116107 Korrespondanse (Hovedbrev inn)
08-01 Korrespondanse (Hovedbrev inn) Korrespondanse (Hovedbrev inn)
08-02 Krav Krav ren
08-03 Hovedbrev Hovedbrev
08-04 Krav Krav merket
Innkommende Hovedbrev E-post
07-01 Korrespondanse (Hovedbrev inn) Hovedbrev E-post
07-02 Annet dokument Realitetsuttalelse
Utgående Realitet patent
06-01 Brev UT Realitet patent
06-02 Vedlegg PT report 04:41:51
Innkommende, AR112015882 Korrespondanse (Hovedbrev inn)
05-01 Korrespondanse (Hovedbrev inn) Korrespondanse (Hovedbrev inn)
05-02 Fullmakt Leogriff DELEGATION OF IP.COOP Power of Attorney NO and EN VALEA 2013
05-03 Fullmakt Generalfullmakt_IFE_til_Leogriff
05-04 Fullmakt Generalfullmakt_Leogriff_til_IPRsa-I
05-05 Erklæring: Søkers rett til oppfinnelse Erklæring Søkers rett til oppfinnelse
Utgående Formalia 1
03-01 Via Altinn-sending Formalia 1
Utgående Infobrev til oppfinner
02-01 Brev UT Infobrev til oppfinner
Innkommende, AR111504233 Korrespondanse (Hovedbrev inn)
04-01 Korrespondanse (Hovedbrev inn) Korrespondanse (Hovedbrev inn)
04-02 Beskrivelse Beskrivelse
Innkommende, AR111499197 Søknadsskjema Patent
01-01 Søknadsskjema Patent Søknadsskjema Patent
01-02 Fullmakt Fullmakt
01-03 Fullmakt Fullmakt
01-04 Beskrivelse Beskrivelse

Til betaling:

Beskrivelse Forfallsdato Beløp Status
Årsavgift expand_less Ikke betalt
Årsavgift 11. avg.år. 4550,0 Totalbeløp 4550,0   Gå til betaling

Betalingshistorikk:

Liste av betalinger
Beskrivelse / Fakturanummer Betalingsdato Beløp Betaler Status
Årsavgift 10. avg.år. 2024.07.19 4160 CPA GLOBAL (PATRAFEE) AB Betalt og godkjent
Årsavgift 9. avg.år. 2023.08.01 2850 renewals.stockholm@cpaglobal.com Betalt og godkjent
Årsavgift 8. avg.år. 2022.07.26 2550 CPA GLOBAL (PATRAFEE) AB Betalt og godkjent
Årsavgift 7. avg.år. 2021.07.09 2200 VALEA AB Betalt og godkjent
Årsavgift 6. avg.år. 2020.07.17 2000 Kristina Hallgren Betalt og godkjent
Årsavgift 5. avg.år. 2019.07.12 1650 Kristina Hallgren Betalt og godkjent
31900823 expand_more 2019.02.21 2450 Valea AB Betalt
Årsavgift 4. avg.år. 2018.07.12 1350 Kristina Hallgren Betalt og godkjent
Årsavgift 1. tom 3. avg.år. 2017.07.10 2100 Valea AB Betalt og godkjent
31509902 expand_more 2015.08.07 5900 IPR SA Betalt
Denne oversikten kan mangle informasjon, spesielt for eldre saker, om tilbakebetaling, internasjonale varemerker og internasjonale design.

Lenker til publikasjoner og Norsk Patenttidende (søkbare tekstdokumenter)

Lenker til publikasjoner (ikke søkbare tekstdokumenter)
Hva betyr A1, B, B1, C osv? info
Kapitler uten data er fjernet. Melding opprettet: 16.07.2025 10:50:57